Form 8-K - Current report:
SEC Accession No. 0001104659-26-029968
Filing Date
2026-03-18
Accepted
2026-03-18 08:51:17
Documents
13
Period of Report
2026-03-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm269191d1_8k.htm   iXBRL 8-K 34091
2 EXHIBIT 99.1 tm269191d1_ex99-1.htm EX-99.1 22463
6 GRAPHIC tm269191d1_ex99-1img001.jpg GRAPHIC 8579
  Complete submission text file 0001104659-26-029968.txt   246678

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ganx-20260318.xsd EX-101.SCH 3038
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20260318_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20260318_pre.xml EX-101.PRE 22374
16 EXTRACTED XBRL INSTANCE DOCUMENT tm269191d1_8k_htm.xml XML 3328
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 26765825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)